Similar articles

• S-carboxymethylcysteine in otitis media with effusion. (A double-blind study).

  Khan JA, Marcus P, Cummings SW. Khan JA, et al. J Laryngol Otol. 1981 Oct;95(10):995-1001. doi: 10.1017/s002221510009174x. J Laryngol Otol. 1981. PMID: 7028897 Clinical Trial.
• s-Carboxy-methyl-cysteine syrup in secretory otitis media.

  Taylor PH, Dareshani N. Taylor PH, et al. Br J Clin Pract. 1975 Jul;29(7):177-8, 180. Br J Clin Pract. 1975. PMID: 1103927 Clinical Trial. No abstract available.
• [Carbocysteine in the treatment of secretory tubotympanic catarrh in childhood].

  Kaspárek L, Vránová M, Sejna I. Kaspárek L, et al. Cesk Otolaryngol. 1988 Dec;37(6):364-8. Cesk Otolaryngol. 1988. PMID: 3233668 Czech. No abstract available.
• Acute otitis media: more trouble with the evidence.

  Wald ER. Wald ER. Pediatr Infect Dis J. 2003 Feb;22(2):103-4. doi: 10.1097/01.inf.0000050363.97163.d8. Pediatr Infect Dis J. 2003. PMID: 12586970 Review. No abstract available.
• Acute otitis media disease management.

  Pichichero ME, Casey JR. Pichichero ME, et al. Minerva Pediatr. 2003 Oct;55(5):415-38. Minerva Pediatr. 2003. PMID: 14608265 Review.